期刊文献+

血液透析滤过对维持性血液透析患者胰岛素抵抗的影响 被引量:4

THE EFFECTS OF HEMODIAFILTRATION ON INSULIN RESISTANCE IN NONDIABETIC PATIENTS WITH MAINTENANCE HEMODIALYSIS
下载PDF
导出
摘要 目的观察不同透析方式对维持性血液透析(MHD)非糖尿病患者胰岛素抵抗(IR)的影响,探讨血液透析滤过(HDF)改善IR的机制。方法将50例MHD患者随机分为两组,常规血液透析组(HD组)和血液透析滤过组(HDF组)。HDF组在常规透析基础上,每隔2周加入血液透析滤过1次,每次4 h,治疗前及治疗6个月后各取血标本检测两组空腹血糖、空腹胰岛素、脂联素、尿酸及hs-CRP;采用IR的体内稳态模型评估方法(HOMA-IR)评估IR;以HOMA-IR作为因变量,体重指数、脂联素、尿酸、hs-CRP作为自变量,分析6个月后胰岛素抵抗指数与各变量间的数量依存关系。结果透析6个月后,HDF组HOMA-IR、尿酸、hs-CRP水平明显低于HD组(P<0.05),脂联素水平明显高于HD组(P<0.05)。多元线性回归显示HOMA-IR与BMI、脂联素无数量依存关系(P>0.05),与尿酸、hs-CRP存在数量依存关系(P<0.05)。结论 HDF可以很好地改善胰岛素抵抗,可能是通过降低hs-CRP水平,减轻患者的微炎症状态这一途径来实现的。 Objective To observe the influence of hemodiafiltration (HDF) on insulin resistance in maintenance hemodialysis nondiabetic patients and to investigate the pathogenic mechanism by which HDF improves the insulin resistance. Methods Fifty nondiabetic patients with MHD were recruited for this study, which were divided into two groups randomly, the HD (treated with HD) and the HDF(treated with HDF every two weekly in addition to HD). The serum fasting blood-glucose and uric acid levels were measured by an oxidase method. Fasting insulin,adiponectin and hs-CRP levels were detected by radioimmunometric assay. Insulin resistance was assessed by using the homeostasis model assessment (HOMA-IR). Results After 6 month observation, the levels of HOMA-IR,serum uric acid and hs-CRP in HDF groups were significantly decreased according to HD groups( P 〈 0.05), the levels of adiponectin were significantly increased according to HD groups( P 〈 0.05). Multiple linear regression analysis showed that changes in uric acid and hs-CRP were found to be significant predictive factors for a change in insulin HOMA-IR after HDF therapy( P 〈0.05). Conclusion HDF can more effectively reduce insulin resistance than HI) therapy, which may achieve it through decreasing the level of hs-CRP and relieving the chromic inflammation.
作者 刘海军
出处 《山东医学高等专科学校学报》 2011年第1期28-30,共3页 Journal of Shandong Medical College
基金 临沂市科技发展计划项目(No.201013065)
关键词 血液透析 血液透析滤过 胰岛素抵抗 Hemodialysis Hemodiafiltration Insulin resistance
  • 相关文献

参考文献10

  • 1叶仁高,李幼姬,刘冠贤.临床肾脏病学[M].第2版.北京:人民卫生出版社,2007:525.
  • 2Becker B,Kronenberg F,Kielstein JT,et al.Renal insulin resistance syndrome,adiponection and cardiovascular events in patients with kidney disease:the mild to moderate kidney disease study[J].J Am Soc Nephrol,2005,16(4):1091-1098.
  • 3Kobayashi S,Maejima S,Ikeda T,et al.Impact of dialysis therapy on insulin resistance in end-stage renal disease:comparison of haemodialysis and continuous ambulatory peritoneal dialysis[J].Nephrol Dial Transplant,2000,15(1):65-70.
  • 4Shinohara K,Shoji T,Emoto M,et al.Insulin Resistance as an Independent Predictor of Cardiovascular Mortality in Patients with End-Stage Renal Disease[J].J Am Soc Nephrol,2002,13(7):1894-1900.
  • 5Gohda T,Gotoh H,Tanimoto M,et al.Relatonship between abdominal fat accumulation and insulin resistance in hemodialysis patients[J].Hypertens Res,2008,31(1):83-88.
  • 6Stefanovic V,Nesic V,Stojimirovic B.Treatment of insulin resistance in uremia[J].Int J Art Organs,2003,26(2):100-104.
  • 7房淑清,范东旭,王长江,霍静琪.血液透析滤过对维持性血液透析患者血清CRP、IL-6的影响[J].中国医药导报,2008,5(14):20-22. 被引量:7
  • 8Zoccali C,Mallamaci F,Tripepi G,et al.Adiponectin,metabolic risk factors,and cardiovascular events among patients with end stage renal disease[J].J Am Soc Nephrol,2002,13(1):134-141.
  • 9Ohashi N,Kato A,Misaki T,et al.Association of serum adiponectin levels with all-cause mortality in hemodialysis patients[J].Inter Med,2008,47(6):485-491.
  • 10孙琦,李玉秀,王姮.脂肪细胞因子与胰岛素抵抗的相关性分析[J].基础医学与临床,2005,25(9):813-817. 被引量:11

二级参考文献12

  • 1[2]Stenvinkel P,Heimburger O,Paultre F,et al.Strong association between malntrition,inflammation and atherosclerosis in chronic renal failure[J].Kidney Int,1999,55:1899-1911.
  • 2[3]Gerge A,kaysen.The microinflammatory state in uremia:causes and potential consequences[J].Jam Soc Nephrol,2001,12:1549-1557.
  • 3[4]Cavaillion JM,Poignet JL,Fitting C,et al.Serum interleukin-6 in Long term hemodialyzed patients[J].Nephrol,1992,60:307-313.
  • 4Wajchenberg BL.Subcutaneous and visecral adipose tissue:their relation to the metabolic syndrome[J].Endocr Rev,2000,21:697-738.
  • 5Hotta K,Matsuzawa Y.Molecular mechanism in the development of the complications associated with obesity-the physiological and pathological role of adipocytokines[J] .Nippon Rinsho,2001,59:481-486.
  • 6Shapiro L,Scherer PE.The crystal structure of a complement 21q family protein suggests an evolutionary link to tumor necrosis factor[J].Curr Biol,1998,12:335-338.
  • 7Sethi J,Hotamisligil GS.The role of TNF-α in adipocyte metabolism[J].Semin Cell Dev Biol,1999,10:19-29.
  • 8Moller DE.Potential role of TNF-α in the pathogenesis of insulin resistance and type 2 diabetes[J].TEM,2000,11 (6): 212-217.
  • 9Weyer C,Funahashi T, Tanaka S, et al.Hypoadiponectinemia in obesity and type 2 diabetes :close association with insulin resistance and hyperinsulinemia[J].J Clin Endocrinol Metab,2001,86 :1930-1935.
  • 10Yamauchi T,Kamon J,Waki H,el al.The fat derived hormone adiponctin reverses insulin resistance associated with both lipoatrophy and obesity[J].Nat Med,2001,7:941-946.

共引文献17

同被引文献32

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部